1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

Clinical Trials GPS Press releases

1 - 10 of 42 Press Releases

Apr 16, 2014
Achieve is conducting a randomized, active and placebo-controlled study to evaluate the efficacy and safety of an experimental drug for preventing flares and reducing serum uric acid in patients with gout.

Apr 15, 2014
Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus.

Mar 13, 2014
Avail is conducting a Phase 2, randomized, placebo-controlled clinical research study to evaluate the safety and efficacy of an experimental ointment for qualified participants with primary osteoarthritis (OA) affecting a single knee joint.

Mar 11, 2014
Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with systemic lupus erythematosus (SLE).

Feb 12, 2014
Avail is conducting a randomized, placebo-controlled study to assess the efficacy, long-term safety and tolerability of a new high cholesterol drug in subjects with primary hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events.

Feb 11, 2014
Achieve is conducting a placebo-controlled study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a new drug in the treatment of subjects with hypertension and type 2 diabetes.

Jan 25, 2014
Achieve is conducting a placebo-controlled study of the efficacy, tolerability and safety of a new high cholesterol drug in reducing the occurrence of major cardiovascular (CV) events in high risk subjects with high cholesterol.

Jan 22, 2014
Avail is conducting a randomized study to evaluate the safety and efficacy of a new hepatitis drug in combinations with simeprevir and/or ritonavir with or without Ribavirin for 12 weeks in participants with chronic hepatitis C infection.

Dec 11, 2013
Paid Arthritis Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with Active Psoriatic Arthritis Age 18 - 75

Dec 10, 2013
Avail is conducting a randomized, vehicle-controlled study to evaluate the safety and efficacy of a advanced form of rectal suppositories in the treatment of adult subjects with symptomatic internal hemorrhoids.


Page:

RSS Feed for Clinical Trials GPS Press Releases